Laser Therapy in Superficial Morphea Lesions—Indications, Limitations and Therapeutic Alternatives
Abstract
:Introduction
Discussions
Conclusions
Acknowledgments
References
- Nouri, S.; Jacobe, H. Recent developments in diagnosis and assessment of morphea. Curr Rheumatol Rep. 2013, 15, 308. [Google Scholar] [CrossRef] [PubMed]
- Reiter, N.; El-Shabrawi, L.; Leinweber, B.; Aberer, E. Subcutaneous morphea with dystrophic calcification with response to ceftriaxone treatment. J Am Acad Dermatol. 2010, 63, e53–e55. [Google Scholar] [CrossRef]
- Jablonska, S.; Blaszczyk, M. Is superficial morphea synonymous with atrophoderma Pasini-Pierini? J Am Acad Dermatol. 2004, 50, 979–980. [Google Scholar] [CrossRef] [PubMed]
- McNiff, J.M.; Glusac, E.J.; Lazova, R.Z.; Carroll, C.B. Morphea limited to the superficial reticular dermis: An underrecognized histologic phenomenon. Am J Dermatopathol. 1999, 21, 315–319. [Google Scholar] [CrossRef]
- Mosbeh, A.S.; Aboeldahab, S.; El-Khalawany, M. Superficial Morphea: Clinicopathological Characteristics and a Novel Therapeutic Outcome to Excimer Light Therapy. Dermatol Res Pract. 2019, 2019, 1967674. [Google Scholar] [CrossRef] [PubMed]
- Srinivasan, S.K.; DiMaio, D. Superficial morphea in a man. J Am Acad Dermatol. 2004, 51 (Suppl 5), S156–S158. [Google Scholar] [CrossRef]
- Peterson, L.S.; Nelson, A.M.; Su, W.P.; Mason, T.; O’Fallon, W.M.; Gabriel, S.E. The epidemiology of morphea (localized scleroderma) in Olmsted County 1960- 1993. J Rheumatol. 1997, 24, 73–80. [Google Scholar]
- Leitenberger, J.J.; Cayce, R.L.; Haley, R.W.; Adams-Huet, B.; Bergstresser, P.R.; Jacobe, H.T. Distinct autoimmune syndromes in morphea: A review of 245 adult and pediatric cases. Arch Dermatol. 2009, 145, 545–550. [Google Scholar] [CrossRef]
- Lu, M.C.; Shyur, S.D.; Lee, L.W.; Hsu, T. Unilateral generalized morphea: First case report in Taiwan [published online ahead of print, 2018 Dec 9]. Asian Pac J Allergy Immunol. 2018. [Google Scholar] [CrossRef]
- Aberer, E.; Neumann, R.; Stanek, G. Is localised scleroderma a Borrelia infection? Lancet. 1985, 2, 278. [Google Scholar] [CrossRef]
- Chan, W.H.; Lewis, D.J.; Kim, E.J.; Aung, P.P.; Duvic, M. Generalized morphea/eosinophilic fasciitis overlap after epoxy exposure. JAAD Case Rep. 2018, 4, 175–178. [Google Scholar] [CrossRef] [PubMed]
- Aberer, E.; Stanek, G.; Ertl, M.; Neumann, R. Evidence for spirochetal origin of circumscribed scleroderma (morphea). Acta Derm Venereol. 1987, 67, 225–231. [Google Scholar] [CrossRef]
- Steuer, A.B.; Peterson, E.; Lo Sicco, K.; Franks, A.G., Jr. Morphea in a patient undergoing treatment with ustekinumab. JAAD Case Reports 2019, 5, 590–592. [Google Scholar] [CrossRef] [PubMed]
- Weide, B.; Walz, T.; Garbe, C. Is morphoea caused by Borrelia burgdorferi? A review. Br J Dermatol. 2000, 142, 636–644. [Google Scholar] [CrossRef] [PubMed]
- Careta, M.F.; Romiti, R. Localized scleroderma: Clinical spectrum and therapeutic update. An Bras Dermatol. 2015, 90, 62–73. [Google Scholar] [CrossRef]
- Fett, N.; Werth, V.P. Update on morphea: Part I Epidemiology, clinical presentation, and pathogenesis. J Am Acad Dermatol. 2011, 64, 217–230. [Google Scholar] [CrossRef]
- Fitzpatrick’s Dermatology in General Medicine, 7th ed.; McGraw-Hill: New York, NY, USA, 2008; pp. 692–701.
- Tatu, A.L.; Nwabudike, L.C. Male genital lichen sclerosus—A permanent therapeutic challenge. J Am Acad Dermatol. 2018, 79, AB185. [Google Scholar] [CrossRef]
- Saleh, Z.; Arayssi, T.; Saleh, Z.; Ghosn, S. Superficial morphea: 20-year follow up in a patient with concomitant psoriasis vulgaris. J Cutan Pathol. 2009, 36, 1105–1108. [Google Scholar] [CrossRef]
- Trivedi, A.; DeWitt, C.M.; McGevna, L. Radiation- induced circumscribed superficial morphea after brachytherapy for endometrial adenocarcinoma. Int J Women Dermatol. 2017, 3, 234–236. [Google Scholar] [CrossRef]
- Tatu, A.L.; Nwabudike, L.C. The Treatment Options of Male Genital Lichen Sclerosus et Atrophicus Short Title for a Running Head. In Proceedings of the 14th national congress of urogynecology and the national conference of the Romanian association for the study of pain; 2017; pp. 262–264. [Google Scholar]
- Yanaba, K.; Umezawa, Y.; Nakagawa, H. A case of radiation-induced generalized morphea with prominent mucin deposition and tenderness. Am J Case Rep. 2015, 16, 279–282. [Google Scholar] [CrossRef]
- Jacobson, L.; Palazij, R.; Jaworsky, C. Superficial morphea. J Am Acad Dermatol. 2003, 49, 323–325. [Google Scholar] [CrossRef] [PubMed]
- Tatu, A.L.; Ionescu, M.A.; Nwabudike, L.C. Contact Allergy to Topical Mometasone Furoate Confirmed by Rechallenge and Patch Test. Am J Ther. 2018, 25, e497–e498. [Google Scholar] [CrossRef]
- Pope, E.; Laxer, R.M. Diagnosis and management of morphea and lichen sclerosus and atrophicus in children. Pediatr Clin North Am. 2014, 61, 309–319. [Google Scholar] [CrossRef] [PubMed]
- Singh, M.; Farquharson, N.; Owen, C.; et al. Morphoea with prominent plasma cell endoneuritis. Clin Exp Dermatol. 2017, 42, 196–199. [Google Scholar] [CrossRef]
- Tatu, A.L.; Cristea, V.C. Pityriasis Folliculorum of the Back Thoracic Area: Pityrosporum, Keratin Plugs, or Demodex Involved? J Cutan Med Surg. 2017, 21, 441. [Google Scholar] [CrossRef] [PubMed]
- Stoian, A.P.; Bala, C.; Rusu, A.; et al. Gender Differences in the Association of Ferritin and 25-hydroxyvitamin, D. Rev Chim. 2018, 69, 864–869. [Google Scholar] [CrossRef]
- Motofei, I.G.; Rowland, D.L.; Baconi, D.L.; et al. Androgenetic alopecia; drug safety and therapeutic strategies. Expert Opin Drug Saf. 2018, 17, 407–412. [Google Scholar] [CrossRef]
- Tatu, A.L.; Nwabudike, L.C. Reply to: Kubiak K et al. Endosymbiosis and its significance in dermatology. J Eur Acad Dermatol Venereol. 2018, 32, e346–e347. [Google Scholar] [CrossRef]
- Wlodek, C.; Korendowych, E.; McHugh, N.; Lovell, C.R. Morphoea profunda and its relationship to eosinophilic fasciitis. Clin Exp Dermatol. 2018, 43, 306–310. [Google Scholar] [CrossRef]
- Stănescu, A.M.A.; Grăjdeanu, I.V.; Iancu, M.A.; Pantea Stoian, A.; Bratu, O.G.; Socea, B.; Socea, L.I.; Diaconu, C.C. Correlation of oral vitamin D administration with the severity of psoriasis and the presence of metabolic syndrome. Rev Chim (Bucharest). 2018, 69, 1668–1672. [Google Scholar] [CrossRef]
- Stoian, A.P.; Bala, C.; Rusu, A.; et al. Oxidative Stress in Diabetes A model of complex thinking applied in medicine. Rev Chim. 2018, 69, 2515–2519. [Google Scholar] [CrossRef]
- Tatu, A.L.; Clatici, V.G.; Nwabudike, L.C. Rosacea-like demodicosis (but not primary demodicosis) and papulopustular rosacea may be two phenotypes of the same disease—A microbioma, therapeutic and diagnostic tools perspective. J Eur Acad Dermatol Venereol. 2019, 33, e46–e47. [Google Scholar] [CrossRef]
- Rowland, D.L.; Motofei, I.G.; Popa, F.; Constantin, V.D.; Vasilache, A.; Paunica, I.; Balalau, C.; Paunica, G.P.; Banu, P.; Paunica, S. The postfinasteride syndrome; an overview. Journal of Mind and Medical Sciences 2016, 3, 99–107. [Google Scholar] [CrossRef]
- Stoian, A.P.; Elian, V.; Nitipir, C.; et al. Association between vitamin d insufficiency and metabolic syndrome. Proceedings of the 3rd International Conference on Interdisciplinary Management of Diabetes Mellitus and its Complications (INTERDIAB), Bucharest, Romania, 2–4 Marth 2017, Sponsor(s): Assoc Renal Metab & Nutrit Studies; AstraZeneca Diabetes; MSD Diabetes; novo nordisk; Sanofi Interdiab 2017: Diabetes Mellitus In Internal Medicine Book Series: International Conference on Interdisciplinary Management of Diabetes Mellitus and its Complications.. Sponsor(s): Assoc Renal Metab & Nutrit Studies; AstraZeneca Diabetes; MSD Diabetes; novo nordisk; Sanofi Interdiab 2017: Diabetes Mellitus In Internal Medicine Book Series: International Conference on Interdisciplinary Management of Diabetes Mellitus and its Complications. 232–242.
- Cunningham, B.B.; Landells, I.D.; Langman, C.; Sailer, D.E.; Paller, A.S. Topical calcipotriene for morphea/linear scleroderma. J Am Acad Dermatol. 1998, 39, 211–215. [Google Scholar] [CrossRef] [PubMed]
- Motofei, I.G.; Rowland, D.L.; Baconi, D.L.; Georgescu, S.R.; Paunica, S.; Constantin, V.D.; Balalau, D.; Paunica, I.; Balalau, C.; Baston, C.; Sinescu, I. Therapeutic considerations related to finasteride administration in male androgenic alopecia and benign prostatic hyperplasia. Farmacia. 2017, 65, 660–666. [Google Scholar]
- Tatu, A.L.; Cristea, V.C. Unilateral Blepharitis With Fine Follicular Scaling. J Cutan Med Surg. 2017, 21, 442. [Google Scholar] [CrossRef]
- Dumitru, N.; Cocoloș, A.; Caragheorgheopol, A.; Dumitrache, C.; Bratu, O.G.; Neagu, T.P.; Diaconu, C.C.; Ghemigian, A. Collagen—The ultrastructural element of the bone matrix. Rev Chim. 2018, 69, 1706–1709. [Google Scholar] [CrossRef]
- Diaconu, C. Midaortic syndrome in a young man. Cor et Vasa 2017, 59, e171–e173. [Google Scholar] [CrossRef]
- Gruss, C.; Reed, J.A.; Altmeyer, P.; McNutt, N.S.; Kerscher, M. Induction of interstitial collagenase (MMP-1) by UVA-1 phototherapy in morphea fibroblasts. Lancet 1997, 350, 1295–1296. [Google Scholar] [CrossRef]
- Georgescu, S.R.; Tampa, M.; Paunica, S.; Balalau, C.; Constantin, V.; Paunica, G.; Motofei, I. Distribution of post-finasteride syndrome in men with androgenic alopecia; ESDR-Congress 2015. Journal of Investigative Dermatology (abstract) 2015, 135, S40. [Google Scholar]
- El-Mofty, M.; Mostafa, W.; Esmat, S.; et al. Suggested mechanisms of action of UVA phototherapy in morphea: A molecular study. Photodermatol Photoimmunol Photomed. 2004, 20, 93–100. [Google Scholar] [CrossRef] [PubMed]
- Hassani, J.; Feldman, S.R. Phototherapy in Scleroderma. Dermatol Ther (Heidelb). 2016, 6, 519–553. [Google Scholar] [CrossRef] [PubMed]
- Kroft, E.B.; Berkhof, N.J.; van de Kerkhof, P.C.; Gerritsen, R.M.; de Jong, E.M. Ultraviolet A phototherapy for sclerotic skin diseases: A systematic review. J Am Acad Dermatol. 2008, 59, 1017–1030. [Google Scholar] [CrossRef] [PubMed]
© 2020 by the author. 2020 Alin Laurentiu Tatu, Diana Sabina Radaschin, Vlad Denis Constantin, Paunica Stana, Valeriu Ardeleanu
Share and Cite
Tatu, A.L.; Radaschin, D.S.; Constantin, V.D.; Stana, P.; Ardeleanu, V. Laser Therapy in Superficial Morphea Lesions—Indications, Limitations and Therapeutic Alternatives. J. Mind Med. Sci. 2020, 7, 46-51. https://doi.org/10.22543/7674.71.P4651
Tatu AL, Radaschin DS, Constantin VD, Stana P, Ardeleanu V. Laser Therapy in Superficial Morphea Lesions—Indications, Limitations and Therapeutic Alternatives. Journal of Mind and Medical Sciences. 2020; 7(1):46-51. https://doi.org/10.22543/7674.71.P4651
Chicago/Turabian StyleTatu, Alin Laurentiu, Diana Sabina Radaschin, Vlad Denis Constantin, Paunica Stana, and Valeriu Ardeleanu. 2020. "Laser Therapy in Superficial Morphea Lesions—Indications, Limitations and Therapeutic Alternatives" Journal of Mind and Medical Sciences 7, no. 1: 46-51. https://doi.org/10.22543/7674.71.P4651
APA StyleTatu, A. L., Radaschin, D. S., Constantin, V. D., Stana, P., & Ardeleanu, V. (2020). Laser Therapy in Superficial Morphea Lesions—Indications, Limitations and Therapeutic Alternatives. Journal of Mind and Medical Sciences, 7(1), 46-51. https://doi.org/10.22543/7674.71.P4651